(Q39420214)

11 September 2017

title

A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia (English)

1 reference

11 September 2017

0 references

1 reference

Talley NJ

1

1 reference

11 September 2017

Van Zanten SV

2

1 reference

11 September 2017

Saez LR

3

1 reference

11 September 2017

Dukes G

4

1 reference

11 September 2017

Perschy T

5

1 reference

11 September 2017

Heath M

6

1 reference

11 September 2017

Kleoudis C

7

1 reference

11 September 2017

Mangel AW

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Alimentary Pharmacology & Therapeutics

11 September 2017

published in

1 reference

11 September 2017

volume

15

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

525-537

1 reference

AGA technical review: evaluation of dyspepsia. American Gastroenterological Association

11 September 2017

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

A national survey of practice patterns of gastroenterologists with comparison to the past two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Economic costs of functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Gastric emptying rate of solids in patients with nonulcer dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Abnormal visceral perception in patients with functional dyspepsia: use of cerebral potentials evoked by electrical stimulation of the oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Use of a novel electronic data collection system in multicenter studies of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Review article: gender-related differences in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

Gastrointestinal sensory function in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00941.X

10.1046/J.1365-2036.2001.00941.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference